Advertisement

Topics

Memorial Sloan Kettering Cancer Center Company Profile

12:49 EDT 20th June 2018 | BioPortfolio

The CMO’s Structure, Assets, and Goals


News Articles [3572 Associated News Articles listed on BioPortfolio]

Memorial Sloan Kettering provides roadmap for successful CAR-T cell program

An article from the Memorial Sloan Kettering Cancer Center (MSK) analyses what it identifies as the key…

Phase III Trial Show That the Combo of Ipilimumab and Nivolumab Increases Overall Survival in People with Kidney Cancer

NewsTreating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus...

Fate expands off-the-shelf CAR T-cell drug partnership with cancer center

Memorial Sloan Kettering Cancer Center granted Fate Therapeutics exclusive rights to additional intellectual property coverin -More- 

BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs

This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the ...

Lilly appoints Maura Dickler as VP of late phase oncology development

She will join the pharma firm from the Memorial Sloan Kettering Cancer Center

Helsinn: Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center

Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Cen...

Midatech gets US green light to begin trials on a drug that may offer hope to suffers of fatal childhood cancer

The study will be conducted at the University of Southern California, San Francisco, and the Memorial Sloan Kettering Cancer Center in New York

Study provides first systematic survey of metabolites across tumour types

In an advance reminiscent of the earliest maps of genomic mutations in cancer, investigators at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center have completed the first systema...

PubMed Articles [6571 Associated PubMed Articles listed on BioPortfolio]

Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.

To evaluate the agreement between multiparametric Magnetic Resonance Imaging (mpMRI), Partin tables (PT) and the Memorial Sloan Kettering Cancer Center nomogram (MSKCCn) in assessing risk category in ...

Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Products at Memorial Sloan Kettering Cancer Center.

Two commercial Chimeric Antigen Receptor (CAR) T cell therapies for CD19 expressing B cell malignancies, Kymriah and Yescarta, have recently been approved by the FDA. The administration of CAR T cells...

Reducing informal caregiver burden in cancer: evidence-based programs in practice.

Caring for people with cancer can be a burdensome and emotionally straining experience. Without adequate psychosocial support, distressed caregivers are at risk for psychiatric and medical morbidity, ...

External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study.

The present study aimed to validate and compare the predictive accuracies of the Memorial Sloan Kettering Cancer Center (MSKCC) and Johns Hopkins University (JHU) web-based postoperative nomograms for...

Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.

Gelfoamhistoculture was utilized to develop the histoculture drug response assay (HDRA) for head and neck cancer. Specimens of head and neck tumors were evaluated for sensitivity to the following drug...

Clinical Trials [9786 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

A Randomized Study of Sulindac in Oral Premalignant Lesions

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or...

Older Breast Cancer Patients: Risk for Cognitive Decline

The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore which domains are most affected, measure associations between cog...

Companies [2807 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

The CMO’s Structure, Assets, and Goals

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

More Information about "Memorial Sloan Kettering Cancer Center" on BioPortfolio

We have published hundreds of Memorial Sloan Kettering Cancer Center news stories on BioPortfolio along with dozens of Memorial Sloan Kettering Cancer Center Clinical Trials and PubMed Articles about Memorial Sloan Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Memorial Sloan Kettering Cancer Center Companies in our database. You can also find out about relevant Memorial Sloan Kettering Cancer Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record